Member Info for RuckRover

(For balance!)

We have a few jokers as well.

WF,
Well they do say "no news is good news"

Davy,
"Has anyone got any further information?"

Believe me, if anyone knew anything it would be all over this board in an instant.
The company will have further information but they have chosen not to divulge yet. It will come soon I'm sure.

TF,
We are fine thank -I had Covid a few weeks back but over it now.

TF,
Where are you?

C11,
Chant whatever mumbo jumbo you like LOL.

C11,
"Alternatively, wait for the Golden Cross to do its stuff"

Probably news will come first.
As I've already posted, the Golden Cross is simply when a short term moving average crosses over a long term ma.
As the long term average lags behind a short term average, a share that is on a long term upward trend will already have the ST MA above the LT MA and the cross will never appear. It really is a primitive way of detecting a trend (badly).

C11,
Fortunately for some of us, membership of the happy clappy glee club is not a pre-requisite of share ownership.

Ivy,
I agree with what you are saying. I'm not expecting Covidity to fail but just highlighting the risks of pursuing multiple pipelines. If one DID fail it would affect Scancell as a whole. I don't think investors would be smart enough to differentiate the risks as they apply to the different drugs and would lump them in as one.

The Scancell team on the whole is skewed towards scientific research. I think there needs to be strengthening in other business areas - sales and marketing, planning, finance strategy etc.

chester,

"Success with the Covidity Vaccine will see huge interest in our Immunobody platform"
Yes, but failure on Covidity will not only impact immunobody but the entire pipeline - justified or not.

Burble,
"I know LD has a lot on her plate, but I wonder if she fancies a stab at making a new Ebola vaccine."

I think a 100% solution to one disease would be more beneficial than a 90% solution to 20 diseases (to both patients and investors) .

C11,

"Hey C7. Does Covidity have a “decreasing value?”
Open to debate I guess."

Whether it does or not remains to be seen. However, I think the value of a potential Covid vaccine was deemed higher at the peak of the pandemic than it does now when everyone seems to think it has gone away. That perception could change quite swiftly.

Lofas,

I guess you're too young to remember the momentous breaking news of August 2012 on the Moditope discovery announcement?

Wtp,

This one is significant - this is in the RNS...

"This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR)."

Chelsea,
Are you including those "holding strong" for a few days and then selling in that group?

Ray,

Perhaps I could add a comment as someone who examines data and produces forecasts for a living.

The primary method of forecasting is to use past history, look for trends and project these forwards.
The dilemma for forecasters is do you use old data or recent data to calculate average. Recent data is more "up to date" and may reflect more accurately what is happening right now and therefore what might happen in the future but suffers from being volatile. Old data is more stable as will smooth out random fluctuations but can "out of date" ie, lags behind what is happening now.

All a golden cross indicates is that a moving average using recent data has risen above a moving average using older data. It is quite a primitive method of assessing trend - you should spot a rising (or falling) trend long before to charts intersect. Whether an upward trend will continue into the future will depend on a whole load of other factors.

If you spot a golden cross early, you might make some money getting in before other people notice the golden cross and start buying. It may work on blue chips but unlikely on a small stock like Scancell. This will be driven by data and news.

So in a way you are both right - each to his own I guess. AIMHO.

TF,
"But to start censoring Inan from this BB now, after many years of enjoying his science inputs"

I'd hardly call pointing out we haven't had an RNS about toxicity a useful "science input". He must think we are a bunch of morons. Oh hang on, it was posted on the other board so fair enough.

DeAar,
Apology accepted. I thought my post was fairly innocuous- merely commenting on the wording of a post.

TF,
"'. I know very well how difficult Inan is but you cannot deny all he has contributed on these BB's, over the years. I'm sure that most on the SCLP BB's would say the same"

I'm sure you're right. He says what people want to hear - £8 per share with no risk - lovely.